Marzetti Q1 Sales Fall 2.4% to $481.5 Million; Diluted EPS at $1.07

What happened

Marzetti reported first-quarter net sales of $481.5 million, down 2.4% from a year earlier, and diluted EPS of $1.07. The company cited the cyclospora outbreak, lower production volumes, higher freight costs and commissioning costs as pressures on results.

Confirmed

Global impact / market context

Gross margin fell to 23.0% from 24.1%, meaning less profit kept per sale after product costs, while operating income dropped $17.8 million. Higher freight and commissioning costs, which means setup expenses for new equipment, show cost pressure beyond the outbreak itself.

Analyst inference

Retail sales grew 2.0% on $17.8 million from Bachan's, but the outbreak cut Retail sales about 4% and Foodservice about 2%. Foodservice sales fell 6.9%, or 2.6% excluding prior-year temporary supply agreement sales, showing broad weakness.

Analyst inference

What to watch

1. Watch whether Retail sales growth from Bachan's continues, since it added $17.8 million and its scanner sales rose 10.7%, offsetting some outbreak-related weakness. Confirmed
2. Watch whether management discloses estimates for outbreak-related sales losses in coming quarters, so investors can judge if the roughly 4% Retail and 2% Foodservice hits are temporary. Proposed
3. Watch gross margin, which fell to 23.0% from 24.1%, for signs freight and commissioning costs are easing, since that would help profit recover without sales growth. Analyst inference

Evidence

• Original source link unavailable